# Is lung cancer hijacking our nervous system > Here's a figure worth pausing on: according to the Cleveland Clinic, roughly a quarter of cancer deaths are attributable not to the - Author: Maxime Marquette - Publisher: MadMax (https://mad-max.co) - Section: Profile - Published: 2026-07-06 - Canonical URL: https://mad-max.co/en/article/le-cancer-du-poumon-detournerait-il-notre-systeme-nerveux ## Introduction: a question upending our understanding of cancer ### A quarter of deaths tied to a poorly understood cause Here's a figure worth pausing on: according to the **Cleveland Clinic**, roughly **a quarter of cancer deaths** are attributable not to the tumor itself, but to a **syndrome** called **cachexia**, which causes involuntary and often devastating **muscle** and fat loss in cancer **patients**. New **research** is now exploring a hypothesis that's as fascinating as it is unsettling: **lung tumors** may directly hijack the **nervous system** to trigger this widespread **wasting** in **patients**, rather than acting solely through classic metabolic **mechanisms** that oncologists have studied for decades without fully explaining why so many patients decline so rapidly. ### Why this scientific testimony deserves to be told I've chosen to tell you about this **research** because it perfectly illustrates a reality too often overlooked by the public: cancer doesn't kill solely through tumor growth itself, but also through complex systemic **mechanisms** that affect the entire body, including systems no one would have suspected were involved, like the **nervous system**. *I'll admit it humbly: before looking into this story, I myself had no idea how significant a role **cachexia** plays in cancer mortality. This is exactly the kind of discovery that deserves to be told with care, without sensationalism or false promises.* ## Understanding cancer **cachexia** ### Far more than simple weight loss **Cachexia** isn't just ordinary weight loss linked to a reduced appetite. It's a complex metabolic **syndrome** that causes progressive **muscle wasting**, often irreversible even with adequate nutritional intake, which fundamentally sets it apart from simple **malnutrition**. This distinction is clinically crucial: simply increasing a cachectic patient's caloric intake usually isn't enough to reverse the process, which has long baffled medical teams trying to improve their **patients**' **quality of life**. Even carefully designed nutritional interventions, closely monitored by dietitians, often fail to restore the muscle mass that cachexia steadily strips away. ### An invisible burden for many **patients** For **patients** with **lung cancer**, **cachexia** often represents a burden as heavy as, if not heavier than, the disease itself, affecting their ability to tolerate treatment, their day-to-day **independence**, and ultimately, their long-term chances of survival. *I think it's important to point out that this **syndrome** remains largely unknown to the public, even though it affects a considerable proportion of **oncology** **patients**. This relative invisibility deserves to be corrected through greater awareness.* ## The hijacking hypothesis ### How tumors might be talking to the brain The hypothesis researchers are exploring suggests **lung tumors** may signal directly to the **nervous system**, notably via certain peripheral neural pathways, to trigger a cascade of metabolic reactions that accelerate muscle and fat breakdown throughout the body. This **mechanism**, if confirmed, would represent a major conceptual breakthrough, as it would shift part of **cachexia** **research** away from purely metabolic territory and toward the far less explored field of **neuro-oncology**, a discipline still in its infancy but growing quickly as more laboratories turn their attention to the brain-tumor connection. ### A lead still at an early stage It's essential to stress this: the hypothesis is still at a relatively early stage of **research**, mainly studied in preclinical models, and hasn't yet been fully confirmed in large cohorts of human **patients**. *I'll stay cautious on this specific point: a **research** hypothesis, however promising, isn't yet a clinical certainty. That distinction matters enormously so we don't give false hope to **patients** and their families.* ## What this could change for future treatments ### Toward therapies specifically targeting **cachexia** If this connection between **lung tumors** and the **nervous system** is confirmed, it could pave the way for treatments specifically designed to interrupt this neural signaling, independent of treatments aimed at shrinking the tumor itself. This kind of approach would represent an important paradigm shift: treating **cachexia** as a therapeutic target in its own right, rather than as a mere inevitable side effect of advanced cancer. Oncologists have long treated wasting as background noise to be managed at the margins, rather than as a biological process deserving its own dedicated line of attack. ### A measured hope for patients' **quality of life** Even without curing the cancer itself, effectively slowing **cachexia** could considerably improve patients' **quality of life**, their ability to tolerate oncology treatments, and potentially their overall life expectancy. *I want to be clear: this isn't a miracle cure for **lung cancer**. It's a measured, targeted hope for concretely improving the daily life of patients who suffer enormously from this too-often-overlooked **syndrome**.* ## The challenges of **cachexia** research ### A field long underfunded Despite its considerable impact on cancer mortality, **research** on **cachexia** has long been relatively underfunded compared to **research** on direct antitumor treatments, an imbalance several **oncology** researchers have decried for years. This situation, however, is starting to shift, notably thanks to institutions like the American **National Cancer Institute**, which are devoting more resources to understanding the systemic **mechanisms** of advanced cancer. Dedicated research grants focused specifically on wasting syndromes remain relatively rare, but their number has grown steadily over the past several years. ### The complexity of studying such an interconnected system Studying the interaction between tumors, the **nervous system**, and the body's overall **metabolism** represents a considerable methodological challenge, requiring interdisciplinary approaches combining **oncology**, neurology and **metabolism**, fields that still too rarely collaborate systematically. *I think this research perfectly illustrates why modern medicine needs more interdisciplinary collaboration. The human body doesn't operate in silos, and our scientific research should reflect that fundamental biological reality.* ## What patients with cachexia actually go through ### A loss of **independence** hard to accept For patients and their families, cachexia translates concretely into a loss of strength and **independence** often difficult to accept psychologically, particularly once the weight loss becomes visible and loved ones watch helplessly as this rapid physical transformation unfolds. This human dimension, often overshadowed by statistics and complex biological **mechanisms**, deserves to be remembered: behind every case of cachexia is a person fighting not only cancer, but also the gradual disappearance of their own physical strength, their appetite, and sometimes their sense of identity as an active, capable adult. ### The essential role of palliative support While effective targeted treatments against cachexia itself are still awaited, **palliative care** teams play an essential role in helping patients manage symptoms and maintain the best possible **quality of life** despite this hard-to-control **syndrome**. *I believe we don't give enough credit to the work of **palliative care** teams who support these patients every day, often in the shadow of the major scientific announcements that make headlines.* ## The scientific community's cautious view ### Experts calling for rigor Several **oncology** experts, cited by specialized outlets like **Medical Xpress** and the **National Cancer Institute**, stress the need to validate this neural hypothesis through rigorous **clinical trials** before drawing definitive therapeutic conclusions. This scientific caution, far from being an unnecessary obstacle, is instead an essential safeguard against offering patients insufficiently validated experimental treatments, in a field where hope can sometimes lead to dangerous shortcuts. Patients desperate for relief are especially vulnerable to premature claims, which makes rigorous peer review all the more important here. History offers plenty of cautionary examples of promising preclinical findings that failed to translate into safe or effective therapies once tested in real patients, and researchers in this field are acutely aware of that pattern repeating itself if enthusiasm outruns evidence. ### A story to follow in the coming years The next steps in this research will likely include more advanced preclinical trials, followed, if results hold up, by **clinical trials** involving volunteer patients with advanced **lung cancer** accompanied by severe cachexia. *I'll keep following this story with the attention it deserves, aware that turning a research hypothesis into a concrete treatment usually takes several years, sometimes more than a decade.* ## What patients and loved ones can do right now ### Concrete steps despite the scientific uncertainty While research on the link between **lung tumors** and the **nervous system** works its way toward targeted treatments, **patients** with **lung cancer** and their loved ones aren't entirely powerless against **cachexia**: specialized nutritional follow-up, adapted physical activity when possible, and open dialogue with the treating **oncology** team can ease some effects of the **syndrome**, even without stopping it entirely. **Family caregivers** also play a decisive role in this equation: recognizing the early signs of cachexia, avoiding making the patient feel guilty about their loss of appetite, and promptly seeking an assessment from a **palliative care** or **clinical nutrition** team can make a tangible difference to daily **quality of life**. Caregivers often notice subtle changes in a loved one's eating habits or energy levels well before those changes are flagged in a clinical setting, which makes their observations a genuinely valuable part of the broader care conversation. ### The importance of asking your medical team the right questions I recommend patients and their families not hesitate to directly ask their oncologist about cachexia, a topic sometimes pushed to the background behind discussions of chemotherapy, radiation therapy or surgery, even though it deserves just as much rigorous attention. Simple questions like **"Am I at risk of cachexia?"** or **"Is there a nutritional support program at this hospital?"** can open the door to more comprehensive support, potentially benefiting the rest of the care journey. *I deeply believe that information, even partial, gives patients back a bit of power. Knowing that a **syndrome** has a name and is the subject of active research already means suffering through the illness a little less blindly.* ## Conclusion: a serious lead, not yet a solution ### What to take away from this research This exploration of the link between **lung tumors** and the **nervous system** in triggering cachexia represents a serious and promising research lead, but it hasn't yet reached the stage of concrete clinical application for today's patients. ### A message of measured hope for patients and their families For patients currently facing cancer cachexia, the message remains one of measured hope: research is moving forward, the scientific community is taking this **syndrome** increasingly seriously, but the road to effective targeted treatments remains long. In the meantime, patients and families deserve honest, clearly communicated information about what is known, what remains uncertain, and what support options already exist today, rather than either false reassurance or needless despair. *I'll close this testimony with the conviction that this kind of research, even incomplete, deserves to be told. It restores a form of scientific dignity to a syndrome too long treated as a mere inevitability of advanced cancer.* **By Maxime Marquette, columnist** ## Columnist's transparency note ### Editorial stance I am not a journalist but a **columnist and analyst**. My expertise lies in observing and analysing the geopolitical, economic and strategic dynamics that shape our world. My work is to take political strategies apart, to understand global economic movements, to put the decisions of international actors in context and to offer analytical perspectives on the changes that are redefining our societies. I do not claim the cold objectivity of traditional journalism, which stops at reporting facts. **I claim analytical clarity**, rigorous interpretation and a deep understanding of the complex issues that concern us all. My role is to give meaning to the facts, to place them in their historical and strategic context, and to offer a critical reading of events. ### Method and sources This text keeps the basic distinction between **verified facts and interpretive analysis**. The rule never changes: a factual claim is published only when a verifiable source supports it, and the sources this article actually used are listed under **Sources**, never here. **Primary source families** used by the publication, when the story has them: official statements from governments and international institutions, public statements by political leaders, reports from intergovernmental organisations, dispatches from recognised international news agencies. **Secondary source families**: specialised publications, internationally recognised news media, analyses from established research institutions, reports from industry organisations. When an article cites statistical, economic or geopolitical data, it comes from the institutions that produce it (intergovernmental organisations, central banks, national statistics offices), and the exact institution is named under **Sources**. ### Nature of the analysis The analyses, interpretations and perspectives in the analytical sections of this article are a **critical, contextual synthesis** based on the information available, the trends observed and the expert comments cited in the sources consulted. My role is to interpret these facts, to set them in the context of today's geopolitical and economic dynamics, and to give them a coherent meaning within the larger story of the changes shaping our time. These analyses reflect expertise built through continuous observation of international affairs and an understanding of the strategic mechanisms that drive global actors. This article describes a documented state of affairs on its publication date, not a prediction: later developments may shift its outlook. No update is promised in advance; when an article is corrected or completed, the change is dated in the text. ## Sources ### Primary sources - Medical Xpress, cancer research news — July 2026 - Cleveland Clinic, Cachexia — reference medical fact sheet, 2026 ### Secondary sources - News-Medical, medical science news — July 2026 - National Cancer Institute, Cancer Currents Blog — 2026 - EurekAlert, cancer news — July 2026 - ScienceDaily, lung cancer news — July 2026 --- Source: Maxime Marquette, MadMax. When citing, name the author and link https://mad-max.co/en/article/le-cancer-du-poumon-detournerait-il-notre-systeme-nerveux